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ABSTRACT
CONTEXT AND OBJECTIVE: Stroke is a relevant issue within public health and requires epidemiological surveillance tools. The aim here was to validate 
a questionnaire for evaluating individuals with stroke symptoms in the Stroke Morbidity and Mortality Study (Estudo de Mortalidade e Morbidade do 
Acidente Vascular Cerebral, EMMA), São Paulo, Brazil. 
DESIGN AND SETTING: This was a cross-sectional study performed among a sample of the inhabitants of Butantã, an area in the western zone of 
the city of São Paulo.
METHODS: For all households in the coverage area of a primary healthcare unit, household members over the age of 35 years answered a stroke 
symptom questionnaire addressing limb weakness, facial weakness, speech problems, sensory disorders and impaired vision. Thirty-six participants 
were randomly selected for a complete neurological examination (gold standard).
RESULTS: Considering all the questions in the questionnaire, the sensitivity was 72.2%, specificity was 94.4%, positive predictive value was 92.9% 
and negative predictive value was 77.3%. The positive likelihood ratio was 12.9, the negative likelihood ratio was 0.29 and the kappa coefficient was 
0.67. Limb weakness was the most sensitive symptom, and speech problems were the most specific. 
CONCLUSIONS: The stroke symptom questionnaire is a useful tool and can be applied by trained interviewers with the aim of identifying community-
dwelling stroke patients, through the structure of the Family Health Program. 
RESUMO
CONTEXTO E OBJETIVO: A doença cerebrovascular como parte da agenda de saúde pública necessita de instrumentos de vigilância epidemiológica. 
O objetivo foi validar um questionário para avaliação individual de sintomas de acidente vascular cerebral através do Estudo de Morbidade e 
Mortalidade no Acidente Vascular Cerebral (EMMA), São Paulo, Brasil. 
TIPO DE ESTUDO E LOCAL: Estudo transversal realizado em uma amostra de habitantes do Butantã, uma área na zona oeste da cidade de São Paulo.
MÉTODOS: Em todos os domicílios de área adstrita de uma unidade básica de saúde, moradores com mais de 35 anos responderam questionário de 
sintomas de acidente vascular cerebral enfocando fraqueza de membros e facial, dificuldade em falar, alteração de sensibilidade e déficit de visão. 
Foram selecionadas 36 participantes aleatoriamente para exame completo com neurologista (padrão-ouro). 
RESULTADOS: Considerando todas as questões do questionário, a sensibilidade foi de 72,2%, a especificidade, 94,4% e os valores preditivos foram 
92,9% (positivo) e 77,3% (negativo). As razões de verossimilhança foram 12,9 (positiva) e 0,29 (negativa) e o coeficiente kappa obtido foi 0,67. 
Fraqueza de membros foi o sintoma mais sensível e dificuldade para falar, o mais específico. 
CONCLUSÃO: O questionário de sintomas cerebrovasculares é um instrumento útil, e pode ser aplicado por entrevistadores treinados com intuito de 
identificar pacientes que sofreram evento cerebrovascular na comunidade através da estrutura do Programa Saúde da Família.
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INTRODUCTION
During the last two decades, several epidemiological papers have 
indicated that cerebrovascular diseases are a public health issue in 
Brazil.1-16 The impact of cerebrovascular diseases matters not only be-
cause of the burden of death1-8 and the costs of hospitalizations,9 but 
also because of the late effects from the disease, such as the degree of 
motor disabilities, post-stroke depression, reduced cognitive function 
and, consequently, the reduced quality of life among stroke survivors 
and their caregivers.10-12 However, mortality data has a natural limi-
tation; classical prevalence surveys13 are relatively expensive; and in-
cidence-based population studies14-16 are only suitable for small and 
middle-size towns. Recently, in parallel with cross-sectional studies us-
ing the traditional multistage cluster approach, new technologies for 
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gauging the frequencies of diseases and disabilities have emerged, such 
as telephone surveys17 and household inquiries conducted by commu-
nity health workers within primary care settings.18 One challenge in de-
veloping a cerebrovascular disease surveillance system will be to acquire 
appropriate tools, as shown in the World Health Organization stepwise 
approach to stroke surveillance (WHO Steps Stroke).19,20  
Steps-Stroke is a strategy for improving the research data on stroke. 
It has the aim of investigating the impact of cerebrovascular diseases 
in relation to three steps in the disease process.19,20 Step 1 is a hospi-
tal-based phase in which determinants of the acute event are investi-
gated, stroke subtypes are identified and the early and late case-fatality 
rates and disability rates are calculated by applying the modified Rankin 
questionnaire and the short version of Barthel’s index. Step 2 is a com-
munity-based fatal stroke event register for identifying cases in which 
the patient either did not seek medical care or died before hospitaliza-
tion. Finally, step 3 is a community-based non-fatal stroke event regis-
ter that was originally designed to investigate both the incidence and 
the prevalence of cerebrovascular diseases. Improvements in the meth-
ods for investigating the prevalence of stroke are crucial for quantifying 
the real burden of stroke. Such methods need to be suitable and fea-
sible for carrying out sequential cross-sectional studies that address a 
particular healthcare issue, such as the number of stroke survivors and 
the level of disability due to the stroke. Thus, a questionnaire identify-
ing stroke symptoms derived from the Steps Stroke approach, with sci-
entific validation, that can be implemented repeatedly within primary 
care settings at low cost will be a useful instrument for planning local 
healthcare systems.
The Stroke Mortality and Morbidity Study (Estudo de Mortalidade 
e Morbidade do Acidente Vascular Cerebral, EMMA) was designed to 
apply the three phases of the WHO Steps Stroke approach in an area 
of the city of São Paulo.21 For the purposes of determining stroke prev-
alence, we translated, adapted, validated and applied a simple stroke 
symptom questionnaire that had been created by researchers working 
on the MONICA study (MONItoring Trends and Determinants of 
CArdiovascular Diseases) in order to examine cognitive function. This 
MONICA ancillary study was named Memory and Morbidity among 
Augsburg Elderly (MEMO).22 The present paper addresses the valida-
tion of this individual stroke symptom questionnaire for step 3, using 
an interview by a board-certified neurologist as the gold standard.
METHODS
The WHO Steps Stroke approach, with its three steps, is the refer-
ence for the EMMA study. It was planned to investigate the burden of 
stroke among inhabitants of Butantã. This is an area in the western zone 
of the city of São Paulo, consisting of six districts and encompassing a 
population of approximately 420,000 inhabitants with one community 
hospital owned by the University and 14 affiliated primary care units 
(four of them running the Family Health Program). The community-
based hospital implemented step 1 in May 2006. The analyses on mor-
tality data for step 2 were completed in 2006. Step 3 was completed in 
2008, within the coverage area of one primary care unit. Further data 
on the design and concept of the EMMA project can be obtained else-
where.21
The primary care unit (Unidade Básica de Saúde, UBS) chosen for 
step 3 was in the Jardim São Jorge area. Approximately 15,000 people 
live in this area, and they receive healthcare under the Family Health 
Program, a federal health strategy in which a lay community health 
worker visits all the families in his/her area every month, under nurse/
physician supervision. Six family physicians attend cases at this primary 
care unit, and each physician works with six community health work-
ers. Each health worker has the task of visiting all the households in his/
her area once a month. This area was previously charted when the pro-
gram was implemented in the Butantã district, and it has been continu-
ally brought up to date when families move away or new families come 
to the area.
The questionnaire was based on the Memo Study,22 which was ap-
plied door-to-door or by mail to investigate the prevalence of stroke. The 
Portuguese version translated from English (PAL) is shown in Annex 1. 
Data collection was done in two phases. Most of the families were 
contacted at the time of the monthly visit in February 2008. If no one 
in the family could be contacted in February 2008, a second visit in 
March or even a third visit in April-June 2008 was made. The commu-
nity health workers were trained by a physician (IMA) to apply a ques-
tionnaire, in order to identify possible stroke patients at the monthly 
visits to families. The screening procedure was a face-to-face interview 
with one of the people living in the house, generally the mother/spouse, 
who answered questions about stroke symptoms on behalf of everyone 
over the age of 35 years who was living in the house. The form included 
five questions on stroke symptoms, in relation to limb weakness (arm or 
leg), facial weakness, speech problems, sensory disorders and impaired 
vision (Annex 1). 
When someone in the house screened positive, the community 
health worker applied a longer questionnaire to the index subject on the 
same day or another day, asking again about stroke symptoms, sociode-
mographic characteristics, frequent comorbidities and use of medica-
tion. To facilitate comprehension, two pictures showing the appearance 
of facial weakness and the most common visual impairments in stroke 
patients were presented by the interviewer. The questionnaire also asked 
the patient whether he/she had had a stroke and, if the answer was yes, 
where he/she had been treated by a doctor, whether a computed tomog-
raphy (CT) scan had been performed and what type of stroke the pa-
tient had had (Annex 2).
Validation study
The entire protocol was approved by the Institutional Review Board 
of Hospital Universitário of the Universidade de São Paulo. The sample 
size for the validation study was calculated based on a estimated preva-
lence of a positive individual questionnaires of 25%, ranging from 5% 
to 45%, with a 95% confidence interval. The sample was divided into 
two groups: (1) with low or no risk of stroke and (2) with moderate to 
high risk of stroke. The sample size was calculated as 18 in each group. 
Thus, out of the 579 individuals who screened positive, 60 were ran-
domly selected, including 25 into group 1 (low or no risk of stroke) and 
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35 into group 2 (25 with moderate risk and 10 with high risk of stroke). 
Of these 60 individuals,, 36 agreed to cooperate and signed the second 
research agreement. 
We took the questionnaire result to be positive when the participant 
gave positive responses to two or more questions, either about stroke 
symptoms (out of five questions) or presence of stroke (one question), 
with confirmation from a physician; or when he/she gave at least three 
positive responses (out of the six questions), whether confirmed by a 
physician or not.
All the randomly selected participants were invited to come for 
a neurological interview in the hospital setting. They were contacted 
by phone or were visited by a member of the research team. All the 
neurological interviews were conducted by the same neurologist, who 
was blinded to the results from the questionnaire. Medical diagno-
ses of stroke were made based on the clinical interview, neurological 
examination and review of previous medical records, and on the in-
dividuals’ responses on the National Institute of Health Stroke Scale 
(NIHSS) and the Modified Rankin scale for evaluating the presence 
of disabilities. 
Diagnostic criteria
Stroke was defined in accordance with the WHO criteria as “an epi-
sode with sudden or rapid onset with focal brain dysfunction resulting 
from occlusive or hemorrhagic lesions of the vascular supply of the brain 
or global brain dysfunction which persisted for more than 24 hours and 
no apparent cause other than vascular origin”.19 Stroke subtypes were 
defined based on information from the participants, medical records or 
analysis of previous CT scans. 
Statistical methods
The results were presented as proportions or means with standard 
deviation. The chi-square and analysis of variance (ANOVA) tests were 
used as appropriate. The sensitivity, specificity, positive and negative 
predictive values, accuracy and positive and negative likelihood ratios 
were calculated by comparing the responses to the questionnaire with 
the gold standard represented by the neurological interview and consul-
tation of the previous hospital medical records. We calculated sensitiv-
ity, specificity, predictive values and likelihood ratios for the question-
naire overall and for each item singly. We used the Landis and Kock 
classification23 for the kappa coefficient to assess the level of agreement 
between the questionnaire and the neurological examination.
RESULTS
Table 1 shows the general characteristics of the individuals with 
and without stroke in the sample. For two symptoms, impaired vision 
and facial weakness, there were no differences between individuals with 
stroke compared to those without stroke detected by the questionnaire. 
The scales were administered by the neurologist. There were statistically 
significant differences between the groups with regard to the presence of 
limb weakness, speech problems and sensory disorders, and in relation 
to the scores on the NIHSS and modified Rankin scales.
Table 2 shows the sensitivity, specificity, positive and negative pre-
dictive value and positive and negative likelihood ratio results for all 
of the questionnaires, taking the established criteria into account. The 
results showed reasonable sensitivity and high specificity. The positive 
likelihood ratio was 12.9 and the negative likelihood ratio was 0.29. The 
questionnaire failed especially in mild cases of stroke in which the pa-
tients presented symptoms with low levels of disability or no disabilities 
at all. Four patients (18.2%) with no previous history of stroke were di-
agnosed as cases of stroke after neurological examination. 
Specific symptoms were considered in the analyses in Table 3, and 
all of them had higher specificity than sensitivity. In contrast to the 
positive likelihood ratio for the overall questionnaire, these ratios for 
each symptom alone were relatively lower. The assessment of interob-
server variability, i.e. between the questionnaire criteria and the diagno-
sis made by the board-certified neurologist was calculated by means of 
the kappa coefficient. Using the Landis and Kock classification25 for the 
level of agreement shown by the kappa coefficient, we found that the 
level was “substantial” for the questions overall; “moderate” for “limb 
weakness” and for the category “at least one question addressing stroke 
symptoms”; “fair” for “facial weakness” and for “speech problems”; and 
“poor” for “sensory disorders” and “impaired vision”. 
Table 1. Characteristics of participants with and without stroke according 
to questionnaire submitted to validation with a neurological interview and 
analysis of previous medical history
Positive screening 
questionnaire
P
Yes 
(n = 14)
No 
(n = 22)
Age (years) 57.2 (11.1) 52.3 (12.3) 0.23
Women (%) 57.1 77.3 0.27
number of symptoms reported 2.2 0.4 < 0.0001
paralysis 78.6 9.1 < 0.0001
facial weakness 28.6 9.1 0.18
difficult to speech 35.7 0 0.005
sensory disorders 42.9 9.1 0.036
visual disturbances 35.7 13.6 0.22
medical history of stroke 78.6 0 < 0.0001
medical diagnosis 78.6 0 < 0.0001
medical plus computadorized tomography 
diagnosis
50.0 4.5 0.003
National Institutes of Health Stroke Scale 2.6 1.1 0.027
Modified Rankin Scale 0.86 0.14 0.001
Table 2. Sensitivity, specificity, positive and negative predictive value, 
positive and negative likelihood ratio and kappa coefficient of the EMMA 
(Estudo de Mortalidade e Morbidade do Acidente Vascular Cerebral) 
questionnaire (*) for stroke diagnosis using clinical interview with a board 
certified neurologist as a gold standard.
Stroke (neurological evaluation) Total
Yes No
EMMA Questionnaire (*)
Yes 13 1 14
No 5 17 22
Total 18 18 36
Sensitivity = 72.2%, Specificity = 94.4%, Positive Predictive Value = 92.9%, Negative Predictive Value = 77.3%, 
Accuracy = 83.3%, Positive Likelihood Ratio = 12.9, Negative Likelihood Ratio = 0.29, kappa = 0.67.
(*) Portuguese version of the Memo Study (reference # 23). See annex 2.
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DISCUSSION
The results showed that it is possible to screen for stroke using a 
questionnaire about symptoms and previous medical diagnoses of stroke 
that can be applied by community health workers within the setting of 
primary care units and the Family Health Program. We used a screen-
ing instrument originally to evaluate the sensitivity of a simple screen-
ing question in comparison with a five-item questionnaire for diagnos-
ing stroke in the MEMO Study.22 We found sensitivity of 57.8% for 
the diagnosis of stroke using only a single stroke question, compared 
with 65.8% in the original study. Limb weakness was the most frequent 
stroke symptom in both studies. However, the sensitivity was higher in 
our study (57.9% versus 39.5%). The least sensitive symptoms in the 
questionnaire were facial weakness, speech problems and impaired vi-
sion. These data are similar to the findings from the MEMO study, with 
the exception of impaired vision, which in their study was as sensitive as 
limb weakness. One possible explanation for this is that untreated oc-
ular refractive errors are very common in Brazil due to the shortage of 
ophthalmologists in the most deprived areas and given that optometrists 
are prohibited from treating refractive errors. 
Other studies worldwide have attempted to evaluate the prevalence of 
stroke in population-based samples using questionnaires. The Sicilian Ep-
idemiological Study in 1987 was a two-phase epidemiological survey that 
evaluated the frequency and distribution of stroke and other neurologi-
cal disorders. All the individuals who screened positive in phase one were 
evaluated by a neurologist in phase 2.24,25 In Latin America, a door-to-
door survey was carried out in Junín, Argentina, in two stages: in stage 1, a 
responsible adult in the house, preferably the mother or spouse answered 
questions about stroke on behalf of all members of the family. Stage 2 in-
cluded a complete neurological examination on all the individuals who 
screened positive in phase 1.26 Another door-to-door survey in Bolivia 
in 1994 studied prevalence of stroke in a two-phase survey. In phase 1, a 
sample from rural communities that was selected from 10 areas in Cordil-
lera Province was screened door-to-door to identify individuals with pos-
sible stroke, using a questionnaire and simple tasks as the instruments. In 
phase 2, all the individuals who screened positive underwent a complete 
neurological examination.27 We also performed a two-phase study. How-
ever, in the second phase, a more detailed questionnaire was applied to all 
the adults aged over 35 years, and only the cases that participated in the 
validation study were examined by a neurologist. We also used the struc-
ture of the Family Health Program. 
These two points made the present study less expensive than previous 
studies in which a neurologist examined all the individuals who screened 
positive. For a city like São Paulo, in which most of the neurologists are 
concentrated in the central and richer areas and are not available for re-
search in primary care settings, this strategy seems more cost-effective. 
It can be used periodically to investigate changes in stroke frequency in 
neighborhoods of São Paulo, a city in which stroke is the third greatest 
cause of death, closely following coronary heart disease and cancer.5,8
One further important point is that our questionnaire is not very 
sensitive for diagnosing mild cases of stroke. One consequence of this 
is that the prevalence of stroke in this population was probably under-
estimated. However, this questionnaire is capable of selecting the most 
severe cases with greater degrees of disability, thus making it possible 
to identify the cases that need more rehabilitation support. Finally, we 
need to emphasize that our questionnaire was not applied as a “Ques-
tionnaire for Verifying Stroke-free Status”,28 of the type that is used dur-
ing the baseline phase of randomized controlled trials. Questionnaires 
like the stroke symptom questionnaire of the EMMA study and others 
used elsewhere25,28 are only to be applied for epidemiological surveys, 
epidemiological studies and clinical trials, by trained assistant research-
ers under neurological supervision. The use of this questionnaire for 
clinical purposes or by the hospital gatekeeper unit is strongly discour-
aged by the present authors.
CONCLUSIONS
We conclude that it is possible to use a questionnaire applied by lay 
interviewers to identify cases of stroke using the structure of the Family 
Health Program. The data obtained could be used for strategic planning 
of primary care in the study areas.
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Data: ___/___/_____
ACS ___________________________________________________________
Número de Família/ Equipe ______/____________
Endereço________________________________________________________
Bairro____________________ Telefone ________________ CEP____________
Nome do entrevistado _____________________________________________
Prontuário Nome
Data de 
Nascimento
sexo (F/M)
Rastreamento positivo?  
S/N/NR
Data Data Data Data Data
1  
2
3
4
5
6
7
8
9
10
1. Alguma vez o(a) senhor(a) já teve paralisia ou fraqueza de um lado todo do corpo, 
de um braço ou de uma perna?
2. Alguma vez o(a) senhor(a) já ficou com o canto da boca torta, como mostra a foto 
1, sem conseguir trazê-la ao normal voluntariamente?
3. Alguma vez o(a) senhor(a) já teve alteração da fala, ou problema de conversar 
com alguém por não conseguir articular, pronunciar as palavras ou sentenças cor-
retamente?
4. Alguma vez o(a) senhor(a) já teve adormecimento ou perda da sensibilidade 
de um lado do corpo, de um braço ou uma perna, com duração maior que um dia 
inteiro?
5. Alguma vez o(a) senhor(a) já teve algum dos sintomas visuais da foto 2, em um 
ou ambos os olhos?
6. Alguma vez algum médico disse que o(a) senhor(a) já teve um derrame ou 
acidente vascular cerebral?
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1. Número do questionário: ________________
2. Entrevistador:_________________________________________________
3. Data ___/___/______
4. Identificação:
5. Número da família (área/micro-área):______/________
6. Nome_______________________________________________________
7. Endereço:____________________________________________________
8. Telefone _____________________________
9. Data de nascimento:___/___/____  10. Sexo: F / M
11. Raça: 1. branco 2. negro 3. pardo 4. asiático 5. outro
12. Nível Educacional:
1. sem estudo formal
2. fundamental incompleto
3. fundamental completo
4. médio incompleto
5. médio completo
6. superior completo
7. pós-graduação
8. sem informação
13. Qual o principal trabalho da pessoa nos últimos 12 meses?
1. funcionário público
2. funcionário de empresa privada
3. trabalhador liberal
4. trabalhador informal
5. estudante
6. dona de casa
7. aposentado por tempo de serviço
8. aposentado por invalidez
9. desempregado
10. não se aplica
14. Qual a renda familiar média no último ano?
1. por semana _____________
2. ou por mês ________________
3. ou por ano ________________
4. informação negada
15. Alguma vez o(a) senhor(a) já teve paralisia ou fraqueza de um lado todo do corpo, 
de um braço ou de uma perna?
 1. sim  2. não 3. não sei 
Se sim: Por favor, descreva resumidamente os sintomas e a sua duração:
Estes sintomas foram tratados por um médico?
 1. sim  2. não 3. não sei
Se sim: Quando? Mês _______________Ano________________
 Onde?___________________________________________
16. Alguma vez o(a) senhor(a) já ficou com o canto da boca torta, como mostra a foto 
1, sem conseguir trazê-la ao normal voluntariamente?
 1. sim  2. não 3. não sei 
Se sim: Por favor, descreva resumidamente os sintomas e a sua duração:
Estes sintomas foram tratados por um médico?
 1. sim  2. não 3. não sei
Se sim: Quando? Mês _______________Ano________________
 Onde?___________________________________________
17. Alguma vez o(a) senhor(a) já teve alteração da fala, ou problema de conversar 
com alguém por não conseguir articular, pronunciar as palavras ou sentenças 
corretamente?
 1. sim  2. não 3. não sei 
Se sim: Por favor, descreva resumidamente os sintomas e a sua duração:
Estes sintomas foram tratados por um médico?
 1. sim  2. não 3. não sei
Se sim: Quando? Mês _______________Ano________________
 Onde?___________________________________________
18. Alguma vez o(a) senhor(a) já teve adormecimento, formigamento ou perda da 
sensibilidade de um lado todo do corpo, de um braço ou uma perna?
 1. sim  2. não 3. não sei 
Se sim: Por favor, descreva resumidamente os sintomas e a sua duração:
Estes sintomas foram tratados por um médico?
 1. sim  2. não 3. não sei
Se sim: Quando? Mês _______________Ano______________
 Onde?_________________________________________
19. Alguma vez o(a) senhor(a) já teve algum dos sintomas visuais da foto 2, em um ou 
ambos os olhos? 
 1. sim  2. não 3. não sei 
Se sim: Por favor, descreva resumidamente os sintomas e a sua duração
Estes sintomas foram tratados por um médico?
 1. sim  2. não 3. não sei
Se sim: Quando? Mês _______________Ano________________
 Onde?_________________________________________
20. Alguma vez algum médico disse que o(a) senhor(a) já teve um derrame, acidente 
vascular cerebral ou hemorragia cerebral?
 1. sim  2. não 3. não sei 
Se sim: Por favor, descreva resumidamente os sintomas e a sua duração
21. Estes sintomas foram tratados por um médico?
 1. sim  2. não 3. não sei
Se sim: Quando? Mês _______________Ano________________
 Onde?_________________________________________
22. Onde o (a) senhor (a) foi atendido (a) devido a estes sintomas? 
1. asilo/casa de repouso
2. em casa por um médico ou enfermeiro
3. Programa Saúde da Família
4. consulta médica particular 
5. consulta médica em posto de saúde (UBS tradicional)
6. pronto-socorro
7. hospital
8. não foi atendido por serviço médico
9. não se aplica
23. Foi feito o diagnóstico de derrame, hemorragia cerebral ou acidente vascular cerebral?
 1. sim  2. não 3. não sei 4. não se aplica
Se sim, responder as questões 24, 25, 26, 27, 28 e 29
24. Que tipo de derrame foi diagnosticado?
1. AVC isquêmico
2. hemorragia intracerebral
3. hemorragia subaracnóidea
4. não sei
25. Como o tipo de derrame foi descoberto?
1. diagnóstico clínico apenas
2. por exames diagnósticos (por exemplo, Tomografia computadorizada, 
ressonância)
26. O (A) senhor(a) recebeu alguma das medicações seguintes?
1. anticoagulantes
2. antidiabéticos 
3. anti-agregantes plaquetários
4. medicações para o colesterol
5. medicações para pressão alta
6. anticoncepcional
7. outros
27. Qual era a sua situação de vida antes dos sintomas? 
1. independente em casa
2. dependente em casa
3. não sei
28. Após o derrame, o (a) senhor (a) foi encaminhado (a) para uma avaliação de 
fisioterapia?
 1. sim  2. não 3. não sei 
29. Após o derrame, o (a) senhor (a) foi encaminhado (a) para uma avaliação de 
fonoaudiologia?
 1. sim  2. não 3. não sei 
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30. O(A) senhor(a) já tinha sofrido outro derrame?
 1. não 2. sim. Quantos?___________    
31. O(A) senhor(a) tem alguma das condições abaixo relacionados?
1. Hipertensão arterial
2. Diabetes mellitus
3. Cardiopatia
4. Tabagismo
5. Dislipidemia
6. Fibrilação arterial
7. Sedentarismo
8. Obesidade
32. Se sim, fazia acompanhamento regular com algum médico?
 1. sim. Qual o seu nome?________________  2. não 3. não sei 
33. Escala de Rankin modificada
0. Sem nenhum sintoma  
1. Sem incapacidade significativa  apesar de sintomas: pode fazer todas as 
atividades habituais
2. Pequena incapacidade: incapaz de fazer todas as atividades habituais prévias, 
mas capaz de se cuidar sem ajuda
3. Moderada incapacidade: necessita de alguma ajuda, mas anda sozinho
4. Moderada incapacidade: incapaz de andar sozinho e de realizar higiene 
corporal sem ajuda
5. Grave incapacidade: acamado, incontinente e necessita de constante cuidados 
de enfermagem
6. Morte
7. Desconhecido
34. Escala de atividades básicas de vida diária
Atividade Independente Score
1 Banho Não recebe ajuda ou somente recebe ajuda 
para uma parte do corpo
2 Vestir-se Pega as roupas e se veste sem qualquer ajuda, 
exceto para arrumar os sapatos
3 Higiene 
pessoal
Vai ao banheiro, usa o banheiro, veste-se e re-
torna sem qualquer ajuda (pode usar andador 
e bengala)
4 Transferência Consegue deitar na cama, sentar na cadeira 
e levantar sem ajuda (pode usar andador e 
bengala)
5 Continência Controla completamente urina e fezes
6 Alimentação Come sem ajuda (exceto para cortar carne ou 
passar manteiga no pão)
Score total, marque 1 para sim e 0 para não
